Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,605,130
-$1,226,151 QoQ
Shares Held
20,620
-25.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.82%
of 13F equity value
Holder Rank
#753
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SECTORAL ASSET MANAGEMENT INC holds $26,299,020 across 9 Drug Manufacturers - General names. GILD ranks #6 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,354 | $7,621,178 | |
| 2 | JNJ |
Johnson & Johnson
|
18,218 | $4,626,825 | |
| 3 | AMGN |
Amgen Inc
|
9,210 | $3,335,125 | |
| 4 | ABBV |
AbbVie Inc.
|
12,200 | $3,070,008 | |
| 5 | MRK |
Merck & Co., Inc.
|
21,480 | $2,760,180 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
20,620 | $2,605,130 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
21,150 | $1,218,663 | |
| 8 | PFE |
Pfizer Inc
|
27,500 | $662,200 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,605,130 | 20,620 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,831,281 | 27,490 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,195,204 | 17,885 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,170,050 | 19,550 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,183,030 | 19,690 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,587,841 | 32,020 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,739,504 | 51,310 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,119,689 | 61,065 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,722,083 | 68,825 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,835,141 | 38,705 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,313,714 | 40,905 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,858,961 | 38,150 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,518,801 | 32,682 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,132,329 | 25,700 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,236,392 | 26,050 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,245,516 | 36,400 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,249,884 | 36,400 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,486,250 | 25,000 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,662,769 | 22,900 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,043,112 | 29,250 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,014,155 | 29,250 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,890,427 | 29,250 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,721,583 | 29,550 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,101,031 | 64,900 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,090,021 | 92,150 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,758,474 | 63,650 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||